Splanchnic vein thrombosis
Information
- Disease name
- Splanchnic vein thrombosis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT03080883 | Active, not recruiting | Phase 3 | Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy | July 14, 2017 | May 31, 2025 |
NCT04994158 | Enrolling by invitation | MASCOT Registry of Patients With Myeloproliferative Neoplasms Associated Splanchnic Vein Thrombosis | September 1, 2019 | September 1, 2034 | |
NCT03778502 | Recruiting | DOAC in Unusual Site Venous Thrombosis | October 1, 2019 | December 2024 | |
NCT06262750 | Recruiting | Evaluation of Safety and Efficacy of Anticoagulation Treatment in Patients With Splanchnic Vein Thrombosis: SAPIENT Study | December 1, 2023 | November 1, 2025 | |
NCT06390475 | Recruiting | Optimizing Diagnosis of Splanchic Vein Thrombosis With MRDTI (Rhea) | March 22, 2019 | July 1, 2025 | |
NCT04631458 | Unknown status | Outcomes in Patients With Myeloproliferative Neoplasm and Splanchnic Vein Thrombosis | November 12, 2014 | December 30, 2021 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0030247